Literature DB >> 3888808

The effect of large volume paracentesis on plasma volume--a cause of hypovolemia?

H W Kao, N E Rakov, E Savage, T B Reynolds.   

Abstract

Large volume paracentesis, while effectively relieving symptoms in patients with tense ascites, has been generally avoided due to reports of complications attributed to an acute reduction in intravascular volume. Measurements of plasma volume in these subjects have been by indirect methods and have not uniformly confirmed hypovolemia. We have prospectively evaluated 18 patients (20 paracenteses) with tense ascites and peripheral edema due to chronic liver disease undergoing 5 liter paracentesis for relief of symptoms. Plasma volume pre- and postparacentesis was assessed by a 125I-labeled human serum albumin dilution technique as well as by the change in hematocrit and postural blood pressure difference. No significant change in serum sodium, urea nitrogen, hematocrit or postural systolic blood pressure difference was noted at 24 or 48 hr after paracentesis. Serum creatinine at 24 hr after paracentesis was unchanged but a small but statistically significant increase in serum creatinine (+0.1 +/- 0.3 mg per dl, p less than 0.01) was noted at 48 hr postparacentesis. Plasma volume changed -2.7% (n = 6, not statistically significant) during the first 24 hr and -2.8% (n = 12, not statistically significant) during the 0- to 48-hr period. No complications from paracentesis were noted. These results suggest that 5 liter paracentesis for relief of symptoms is safe in patients with tense ascites and peripheral edema from chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3888808     DOI: 10.1002/hep.1840050310

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  12 in total

1.  Ruptured ascites: 'accidental' massive paracentesis without complication.

Authors:  D O'Mahony; M J Whelton; S O'Mahony
Journal:  Postgrad Med J       Date:  1987-11       Impact factor: 2.401

2.  The hepatorenal syndrome revisited.

Authors:  S P Wilkinson
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

3.  Treatment of ascites in patients with cirrhosis of the liver.

Authors:  V Arroyo; P Ginés; J Rodés
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

Review 4.  Treating the ascites of cirrhosis.

Authors:  M Panos; D Westaby; R Williams
Journal:  BMJ       Date:  1988-09-17

Review 5.  Umbilical hernia rupture in cirrhotics with ascites.

Authors:  S Kirkpatrick; T Schubert
Journal:  Dig Dis Sci       Date:  1988-06       Impact factor: 3.199

6.  Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study.

Authors:  R Moreau; T Asselah; B Condat; C de Kerguenec; F Pessione; B Bernard; T Poynard; M Binn; J D Grangé; D Valla; D Lebrec
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

7.  Manipulation of ascitic fluid pressure in cirrhotics to optimize hemodynamic and renal function.

Authors:  J A Savino; T Cerabona; N Agarwal; D Byrne
Journal:  Ann Surg       Date:  1988-10       Impact factor: 12.969

8.  Concentrated ascitic fluid reinfusion after cascade filtration in tense ascites.

Authors:  L Rossaro; A Graziotto; S Bonato; M Plebani; D H van Thiel; A Burlina; R Naccarato; M Salvagnini
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

9.  Dextran administration avoids hemodynamic changes following paracentesis in cirrhotic patients. A safe and inexpensive option.

Authors:  R Terg; J Berreta; R Abecasis; G Romero; L Boerr
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

10.  Effect of large volume paracentesis performed just prior to transjugular intrahepatic portosystemic shunt on the anesthetic management during the procedure.

Authors:  Hanzhou Li; Zhuo Sun; Nadine Odo; Jayanth H Keshavamurthy; Shvetank Agarwal
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2021-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.